DCLX069

Names

[ Name ]:
DCLX069

[Synonym ]:
MFCD06666140
Benzoic acid, 3-amino-4-[4-(phenylmethyl)-1-piperazinyl]-, ethyl ester
Ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate

Biological Activity

[Description]:

DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 µM. DCLX069 shows less active against PRMT4 and PRMT6. DCLX069 has anticancer effects[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Epigenetics >> Histone Methyltransferase

[Target]

PRMT1:17.9 μM (IC50)

[In Vitro]

DCLX069 (12.5-100 µM) effectively blocks cell proliferation in breast cancer, liver cancer and acute myeloid leukemia cell lines (MCF7, HepG2, and THP1 cells) in a concentration-dependent manner[1].

[References]

[1]. Yiqian Xie, et al. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1). Org Biomol Chem. 2014 Dec 21;12(47):9665-73.

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
515.9±50.0 °C at 760 mmHg

[ Molecular Formula ]:
C₂₀H₂₅N₃O₂

[ Molecular Weight ]:
339.431

[ Flash Point ]:
265.8±30.1 °C

[ Exact Mass ]:
339.194672

[ LogP ]:
2.63

[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C

[ Index of Refraction ]:
1.611

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.